Honoring the legacy of Paul A. Marks, MD, President Emeritus of Memorial Sloan Kettering Cancer Center and a distinguished scientist, the Paul Marks Prize for Cancer Research recognizes outstanding young investigators who have made significant contributions to increase the understanding of cancer or improve the treatment of the disease through basic or clinical research.
The Paul Marks Prize is awarded every other year to up to three investigators. The first recipients were named in 2001. The winners will present their work at a scientific symposium at Memorial Sloan Kettering Cancer Center and share a cash award of $150,000.
Nominations are now being accepted for the 2017 Paul Marks Prize for Cancer Research. Nominees must be age 45 or younger on the date of the submission deadline, April 28, 2017. Prize winners will be announced in Fall 2017.
- A letter from the nominator outlining the significance of the accomplishments for which the candidate is being recognized.
- A one-page scientific biography of the candidate.
- A list of up to eight of the candidate’s most significant published papers with brief explanations (100 words or less) of the importance of each one.
- The candidate’s curriculum vitae.
- Up to three supporting letters (at least one must come from a recommender outside of the nominee’s institution).